Antiviral Activities of Type I Interferons to SARS-CoV-2 Infection
Publication date: Available online 29 April 2020Source: Antiviral ResearchAuthor(s): Emily Mantlo, Natalya Bukreyeva, Junki Maruyama, Slobodan Paessler, Cheng Huang (Source: Antiviral Therapy)
Source: Antiviral Therapy - April 29, 2020 Category: Virology Source Type: research
The involvement of Annexin A1 in human placental response to maternal Zika virus infection
Publication date: Available online 29 April 2020Source: Antiviral ResearchAuthor(s): Rafaela Batista Molás, Milene Rocha Ribeiro, Maria Juliana C Ramalho dos Santos, Alexandre Urban Borbely, Denise Vaz Oliani, Antonio Hélio Oliani, Suchita Nadkarni, Maurício Lacerda Nogueira, Jusciele Brogin Moreli, Sonia Maria Oliani (Source: Antiviral Therapy)
Source: Antiviral Therapy - April 29, 2020 Category: Virology Source Type: research
Artemisinin inhibits the replication of flaviviruses by promoting the type I interferon production
Publication date: Available online 29 April 2020Source: Antiviral ResearchAuthor(s): Xugang Wang, Bohan Zheng, Usama Ashraf, Hao Zhang, Chen Cao, Qi Li, Zheng Chen, Muhammad Imran, Huanchun Chen, Shengbo Cao, Jing Ye (Source: Antiviral Therapy)
Source: Antiviral Therapy - April 29, 2020 Category: Virology Source Type: research
LINCS Dataset-Based Repositioning of Rosiglitazone as a Potential Anti-human Adenovirus Drug
Publication date: Available online 27 April 2020Source: Antiviral ResearchAuthor(s): Xiaolong Wang, Song He, Zhe Zhou, Xiaochen Bo, Dongmei Qi, Xianjun Fu, Zhenguo Wang, Jing Yang, Shengqi Wang (Source: Antiviral Therapy)
Source: Antiviral Therapy - April 28, 2020 Category: Virology Source Type: research
Characterization of contemporary influenza B recombinant viruses harboring mutations of reduced susceptibility to baloxavir marboxil, in vitro and in mice
Publication date: Available online 25 April 2020Source: Antiviral ResearchAuthor(s): Yacine Abed, Clément Fage, Liva Checkmahomed, Marie-Christine Venable, Guy Boivin (Source: Antiviral Therapy)
Source: Antiviral Therapy - April 25, 2020 Category: Virology Source Type: research
Ivermectin and COVID-19: a report in Antiviral Research, widespread interest, an FDA warning, two letters to the editor and the authors' responses
Publication date: Available online 21 April 2020Source: Antiviral ResearchAuthor(s): Mike Bray, Craig Rayner, François Noël, David Jans, Kylie Wagstaff (Source: Antiviral Therapy)
Source: Antiviral Therapy - April 22, 2020 Category: Virology Source Type: research
Coronavirus membrane fusion mechanism offers a potential target for antiviral development
Publication date: June 2020Source: Antiviral Research, Volume 178Author(s): Tiffany Tang, Miya Bidon, Javier A. Jaimes, Gary R. Whittaker, Susan Daniel (Source: Antiviral Therapy)
Source: Antiviral Therapy - April 20, 2020 Category: Virology Source Type: research
TEMPORARY REMOVAL: DDX3 inhibitors show antiviral activity against positive-sense single-stranded RNA viruses but not against negative-sense single-stranded RNA viruses: The coxsackie B model
Publication date: June 2020Source: Antiviral Research, Volume 178Author(s): Paola Quaranta, Giulia Lottini, Giulia Chesi, Flavia Contrafatto, Roberta Russotto, Lisa Macera, Michele Lai, Pietro Giorgio Spezia, Annalaura Brai, Maurizio Botta, Giulia Freer, Mauro Pistello (Source: Antiviral Therapy)
Source: Antiviral Therapy - April 17, 2020 Category: Virology Source Type: research
Antiviral efficacy against Influenza virus and pharmacokinetic analysis of a novel MEK-inhibitor, ATR-002, in cell culture and in the mouse model
Publication date: Available online 15 April 2020Source: Antiviral ResearchAuthor(s): Martin Laure, Hazem Hamza, Julia Koch-Heier, Martin Quernheim, Christin Müller, Andre Schreiber, Gerhard Müller, Stephan Pleschka, Stephan Ludwig, Oliver Planz (Source: Antiviral Therapy)
Source: Antiviral Therapy - April 16, 2020 Category: Virology Source Type: research
In vitro and in vivo growth inhibition of human cervical cancer cells via human papillomavirus E6/E7 mRNAs’ cleavage by CRISPR/Cas13a system
Publication date: Available online 14 April 2020Source: Antiviral ResearchAuthor(s): Yili Chen, Hongye Jiang, Ting Wang, Dan He, Rui Tian, Zifeng Cui, Xun Tian, Qinglei Gao, Xin Ma, Jianrong Yang, Jun Wu, Songwei Tan, Hongyan Xu, Xiongzhi Tang, Yan Wang, Zhiying Yu, Hui Han, Bhudev C. Das, Konstantin Severinov, Inga Isabel Hitzeroth (Source: Antiviral Therapy)
Source: Antiviral Therapy - April 14, 2020 Category: Virology Source Type: research
Editorial Board
Publication date: May 2020Source: Antiviral Research, Volume 177Author(s): (Source: Antiviral Therapy)
Source: Antiviral Therapy - April 14, 2020 Category: Virology Source Type: research
Remdesivir and SARS-CoV-2: structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites
Publication date: Available online 10 April 2020Source: Antiviral ResearchAuthor(s): Ashleigh Shannon, Nhung Thi Tuyet Le, Barbara Selisko, Cecilia Eydoux, Karine Alvarez, Jean-Claude Guillemot, Etienne Decroly, Olve Peersen, Francois Ferron, Bruno Canard (Source: Antiviral Therapy)
Source: Antiviral Therapy - April 11, 2020 Category: Virology Source Type: research
Type 1 interferons as a potential treatment against COVID-19
Publication date: Available online 7 April 2020Source: Antiviral ResearchAuthor(s): Erwan Sallard, François-Xavier Lescure, Yazdan Yazdanpanah, France Mentre, Nathan Peiffer-Smadja, Florence ADER, Yazdan YAZDANPANAH, France MENTRE, François-Xavier LESCURE, Nathan PEIFFER-SMADJA, Lila BOUADMA, Julien POISSY, Jean-François TIMSIT, Bruno LINA, Florence MORFIN-SHERPA, Gilles PEYTAVIN, Charles BURDET, Cedric LAOUENAN, Drifa BELHADI, Axelle DUPONT (Source: Antiviral Therapy)
Source: Antiviral Therapy - April 8, 2020 Category: Virology Source Type: research
Coronavirus membrane fusion mechanism offers as a potential target for antiviral development
Publication date: Available online 6 April 2020Source: Antiviral ResearchAuthor(s): Tiffany Tang, Miya Bidon, Javier A. Jaimes, Gary R. Whittaker, Susan Daniel (Source: Antiviral Therapy)
Source: Antiviral Therapy - April 7, 2020 Category: Virology Source Type: research
p53 and p53-related mediators PAI-1 and IGFBP-3 are downregulated in peripheral blood mononuclear cells of HIV-patients exposed to NNRTI
Publication date: Available online 6 April 2020Source: Antiviral ResearchAuthor(s): Aleksandra Gruevska, Angela B. Moragrega, Maria J. Galindo, Juan V. Esplugues, Ana Blas-Garcia, Nadezda Apostolova (Source: Antiviral Therapy)
Source: Antiviral Therapy - April 7, 2020 Category: Virology Source Type: research
